Autolus follows up CAR T data with $101M raise

Autolus follows up CAR T data with $101M raise

Source: 
BioCentury
News Tags: 
snippet: 

Days after announcing the first response rates from a Phase I/II trial of CAR T cell therapy AUTO1, Autolus raised $100.8 million in a follow-on offering.